Company intelligence / Profile preview

Pixyl

La Tronche, Auvergne-Rhône-Alpes, Francepixyl.ai ↗

Ownership: Private
Development stage: Commercial

Overview

The company’s flagship product, Pixyl.Neuro™, uses proprietary AI algorithms to analyze brain MR images for anomalies related to neuroinflammatory and neurodegenerative diseases. It has received FDA 510(k) clearance and CE mark as a class IIa medical device. The software provides rapid diagnostic support for clinicians by delivering results in under five minutes using minimal MR protocols. Clinical validation includes recognition from the French Society for Radiology Data Challenge.

Therapeutic areas: Neurology
Modalities: DeviceSoftware
Industry: Medical Imaging

Partnerships

Collaborations with radiologists/neuroradiologists at major conferences such as ESNR/ECR

Beyond the preview

Go deeper on Pixyl.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pixyl.

Explore the full profile